Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.58 |
| ▸ | CCKBR | P32239 | 2/20 | 0.58 |
| ▸ | GCGR | P47871 | 5/20 | 0.58 |
| ▸ | C5AR1 | P21730 | 2/20 | 0.57 |
| ▸ | CALCR | P30988 | 4/20 | 0.57 |
| ▸ | NMBR | P28336 | 2/20 | 0.56 |
| ▸ | GRPR | P30550 | 2/20 | 0.56 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.56 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.55 |
| ▸ | GIPR | P48546 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30906336 | 0.97 | GLP1R (0.61) | GLP1RCCKBRGCGRC5AR1CALCR | |
| SCHEMBL30726621 | 0.92 | GLP1R (0.60) | GLP1RCCKBRGCGRC5AR1CALCR | |
| SCHEMBL31000927 | 0.91 | NMBR (0.55) | GLP1RCCKBRGCGRC5AR1CALCR | |
| SCHEMBL38662213 | 0.91 | CALCR (0.60) | GLP1RCCKBRC5AR1CALCR | |
| SCHEMBL30540291 | 0.89 | CALCR (0.61) | GLP1RCCKBRGCGRCALCRNMBR | |
| SCHEMBL29743013 | 0.89 | C5AR1 (0.59) | GLP1RCCKBRGCGRC5AR1CALCR | |
| SCHEMBL29856457 | 0.88 | CALCR (0.57) | C5AR1CALCR | |
| SCHEMBL29588160 | 0.87 | CALCR (0.66) | GLP1RCCKBRGCGRCALCRNMBR | |
| SCHEMBL30658362 | 0.86 | NMBR (0.65) | GLP1RCCKBRGCGRC5AR1CALCR | |
| SCHEMBL29588702 | 0.86 | CALCR (0.64) | GLP1RCCKBRGCGRCALCRNMBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4267193-A1 | IMPROVED CD30 TARGETING ANTIBODY DRUG CONJUGATES AND USES THEREOF | Ludwig-Maximilians-Universität München (DE) | 2023-11-01 | — | — | EP | disclosed |
| WO-2022136555-A1 | IMPROVED CD30 TARGETING ANTIBODY DRUG CONJUGATES AND USES THEREOF | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE) | 2022-06-30 | — | — | WO | disclosed |